Body Image Therapy in Anorexia Nervosa

NCT ID: NCT01437527

Last Updated: 2016-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to test a new procedure of body image therapy in anorexia nervosa, using the anamorphic micro software.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anorexia nervosa is a severe psychiatric disorder, with high level of mortality and hospitalization is often necessary for the treatment of severe and/or chronic cases.

Anorexic patients often experience a serious disturbance in body and their own shape perception. Body image work should be enhanced in the treatment of anorexia nervosa.

The aim of the study is to test a new body image therapy using the anamorphic Micro software.

Ten sessions of assessment of the patient's own shape and of correction of distorted perceptions of body size with Anamorphic Micro software will be compared to ten sessions of body image therapy as usual.

French 100 anorexia women hospitalized in a specialized Eating Disorder Unit will participate to the study, randomized in 2 arms :

* Body image therapy with Anamorphic Micro software
* Body image therapy as usual

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anorexia Nervosa

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Interventional arm

Body image therapy with Anamorphic Micro software

Group Type EXPERIMENTAL

Anamorphic Micro software

Intervention Type BEHAVIORAL

Body image therapy with Anamorphic Micro software

control arm

Body image therapy as usual

Group Type ACTIVE_COMPARATOR

therapy as usual

Intervention Type BEHAVIORAL

Body image therapy as usual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anamorphic Micro software

Body image therapy with Anamorphic Micro software

Intervention Type BEHAVIORAL

therapy as usual

Body image therapy as usual

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* woman
* more than 18 years old
* anorexia nervosa
* hospitalized in the CMME (CHSA) TCA Unit
* Body Mass Index ≥ 16
* Informed consent

Exclusion Criteria

* pregnancy
* severe motor, sensitive or sensorial impairment
* no affiliation of national health service
* dependent of a trusteeship or guardianship
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier St Anne

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alexandra PHAM - SCOTTEZ, MD

Role: PRINCIPAL_INVESTIGATOR

Centre Hospitalier Sainte Anne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centre Hospitalier Sainte Anne

Paris, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2010-A01427-32

Identifier Type: OTHER

Identifier Source: secondary_id

D465

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.